Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation
/February 23, 2022
Journal of General internal Medicine
February 23, 2022
Journal of General internal Medicine
Read MoreThere are no randomized trials and evidence ranges in quality, but evidence for the embryo formation and loss in 4.5 percent of IUD users exists in good-quality research. Further research is needed to compare embryo loss in IUD users to loss in controls.
Read MorePregnancies in women who conceive with a removed or retained copper IUD are at an increased risk for short-term adverse perinatal outcomes, especially preterm delivery. For pregnancies that continued to at least 22 weeks, we found no benefit in IUD removal. However, the risk of long-term neuropsychiatric hospitalizations is not increased among offspring of these women.
Read MoreBaseline generalized pelvic pain may not be a risk factor for IUD discontinuation within one year of placement.
Read MoreJaydess should be used with caution after specialist advice, or removal should be considered in women with existing or new severe headache, migraine, jaundice, severe arterial disease such as stroke or myocardial infarction, or marked increase in blood pressure.
Read More“There was a decrease in contraceptive effectiveness after 12 more months' use.”
Read More“Compared with oral contraceptives copper IUDs have less severe side effects but less safety at the same time-especially for the younger fertile age group. Therefore they should be offered to young nulliparous women only for a limited period of time.”